| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Journal of Lipid Research, Vol 30, 1117-1126, Copyright © 1989 by Lipid Research, Inc.
ARTICLES |
T Kuusi, C Ehnholm, J Viikari, R Harkonen, E Vartiainen, P Puska and MR Taskinen
National Public Health Institute, Helsinki.
To study the role of the two postheparin plasma lipolytic enzymes, lipoprotein lipase (LPL) and hepatic lipase (HL) in high density lipoprotein (HDL) metabolism at a population level, we determined serum lipoproteins, apoproteins A-I, A-II, B, and E, and postheparin plasma LPL and HL activities in 65 subjects with a mean HDL-cholesterol of 34 mg/dl and in 62 subjects with a mean HDL-cholesterol of 87 mg/dl. These two groups represented the highest and lowest 1.4 percentile of a random sample consisting 4,970 subjects. The variation in HDL level was due to a 4.1-fold difference in the HDL2 cholesterol (P less than 0.001) whereas the HDL3 cholesterol level was increased only by 32% (P less than 0.001) in the group with high HDL-cholesterol. Serum apoA- levels were 128 +/- 2.2 mg/dl and 210 +/- 2.8 mg/dl (mean +/- SEM) in hypo- and hyper-HDL cholesterolemia, respectively. Serum apoA-II concentration was elevated by 28% (P less than 0.001) in hyperalphalipoproteinemia. The apoA-I/A-II ratio was elevated only in women with high HDL-cholesterol but not in men, suggesting that elevation of apoA-I is involved in hyperalphalipoproteinemia in females, whereas both apoA proteins are elevated in men with high HDL cholesterol. Serum concentration of apoE and its phenotype distribution were similar in the two groups. The HL activity was reduced in the high HDL-cholesterol group (21.2 +/- 1.5 vs. 38.5 +/- 1.8 mumol/h/ml, P less than 0.001), whereas the LPL activity was elevated in the group with high HDL-cholesterol compared to subjects with low HDL-cholesterol (27.8 +/- 1.3 vs. 19.9 +/- 0.8 mumol/h/ml, P less than 0.001). The HL and LPL activities correlated in opposing ways with the HDL2 cholesterol (r = 0.57, P less than 0.001 and r = 0.51, P less than 0.001, respectively), and this appeared to be independent of the relative ponderosity by multiple correlation analysis. The results demonstrate major influence of both HL and LPL on serum HDL cholesterol concentration at a population level.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. von Eynatten, J. G. Schneider, P. M. Humpert, G. Rudofsky, N. Schmidt, P. Barosch, A. Hamann, M. Morcos, J. Kreuzer, A. Bierhaus, et al. Decreased Plasma Lipoprotein Lipase in Hypoadiponectinemia: An association independent of systemic inflammation and insulin resistance Diabetes Care, December 1, 2004; 27(12): 2925 - 2929. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Carr, J. D. Brunzell, and S. S. Deeb Ethnic differences in hepatic lipase and HDL in Japanese, black, and white Americans: role of central obesity and LIPC polymorphisms J. Lipid Res., March 1, 2004; 45(3): 466 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Cheung, S. D. Sibley, J. P. Palmer, J. F. Oram, and J. D. Brunzell Lipoprotein lipase and hepatic lipase: their relationship with HDL subspecies Lp(A-I) and Lp(A-I,A-II) J. Lipid Res., August 1, 2003; 44(8): 1552 - 1558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Soro, M. Jauhiainen, C. Ehnholm, and M.-R. Taskinen Determinants of low HDL levels in familial combined hyperlipidemia J. Lipid Res., August 1, 2003; 44(8): 1536 - 1544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Ramsamy, J. Boucher, R. J. Brown, Z. Yao, and D. L. Sparks HDL regulates the displacement of hepatic lipase from cell surface proteoglycans and the hydrolysis of VLDL triacylglycerol J. Lipid Res., April 1, 2003; 44(4): 733 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Nieves, M. Cnop, B. Retzlaff, C. E. Walden, J. D. Brunzell, R. H. Knopp, and S. E. Kahn The Atherogenic Lipoprotein Profile Associated With Obesity and Insulin Resistance Is Largely Attributable to Intra-Abdominal Fat Diabetes, January 1, 2003; 52(1): 172 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Su, S. Zhang, D. W. Nebert, L. Zhang, D. Huang, Y. Hou, L. Liao, and C. Xiao A novel allele in the promoter of the hepatic lipase is associated with increased concentration of HDL-C and decreased promoter activity J. Lipid Res., October 1, 2002; 43(10): 1595 - 1601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rashid, P. H. R. Barrett, K. D. Uffelman, T. Watanabe, K. Adeli, and G. F. Lewis Lipolytically Modified Triglyceride-Enriched HDLs Are Rapidly Cleared From the Circulation Arterioscler. Thromb. Vasc. Biol., March 1, 2002; 22(3): 483 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Winkler, B. Wetzka, M. M. Hoffmann, I. Friedrich, M. Kinner, M. W. Baumstark, H. Wieland, W. März, and H. P. Zahradnik Low Density Lipoprotein (LDL) Subfractions during Pregnancy: Accumulation of Buoyant LDL with Advancing Gestation J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4543 - 4550. [Abstract] [Full Text]
|
|
|
|
|
|
S. J. Murdoch, M. C. Carr, J. E. Hokanson, J. D. Brunzell, and J. J. Albers PLTP activity in premenopausal women: relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance J. Lipid Res., February 1, 2000; 41(2): 237 - 244. [Abstract] [Full Text]
|
|
|
|
|
|
H. Allayee, K. M. Dominguez, B. E. Aouizerat, R. M. Krauss, J. I. Rotter, J. Lu, R. M. Cantor, T. W. A. de Bruin, and A. J. Lusis Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia J. Lipid Res., February 1, 2000; 41(2): 245 - 252. [Abstract] [Full Text]
|
|
|
|
|
|
H. E. Henderson, J. J. P. Kastelein, A. H. Zwinderman, E. Gagné, J. W. Jukema, P. W. A. Reymer, B. E. Groenemeyer, K. I. Lie, A. V. G. Bruschke, M. R. Hayden, et al. Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins J. Lipid Res., April 1, 1999; 40(4): 735 - 743. [Abstract] [Full Text]
|
|
|
|
|
|
S. M. Grundy, G. L. Vega, J. D. Otvos, D. L. Rainwater, and J. C. Cohen Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men: genetic and pharmacological evidence J. Lipid Res., February 1, 1999; 40(2): 229 - 234. [Abstract] [Full Text]
|
|
|
|
|
|
A. Zambon, S. S. Deeb, J. E. Hokanson, B. G. Brown, and J. D. Brunzell Common Variants in the Promoter of the Hepatic Lipase Gene Are Associated With Lower Levels of Hepatic Lipase Activity, Buoyant LDL, and Higher HDL2 Cholesterol Arterioscler. Thromb. Vasc. Biol., November 1, 1998; 18(11): 1723 - 1729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Vega, L. T. Clark, A. Tang, S. Marcovina, S. M. Grundy, and J. C. Cohen Hepatic lipase activity is lower in African American men than in white American men: effects of 5' flanking polymorphism in the hepatic lipase gene (LIPC) J. Lipid Res., January 1, 1998; 39(1): 228 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Murtomaki, E. Tahvanainen, M. Antikainen, L. Tiret, V. Nicaud, H. Jansen, and C. Ehnholm Hepatic Lipase Gene Polymorphisms Influence Plasma HDL Levels : Results From Finnish EARS Participants Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 1879 - 1884. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. E. Groenemeijer, M. D. Hallman, P. W.A. Reymer, E. Gagne, J. A. Kuivenhoven, T. Bruin, H. Jansen, K. I. Lie, A. V.G. Bruschke, E. Boerwinkle, et al. Genetic Variant Showing a Positive Interaction With ß-Blocking Agents With a Beneficial Influence on Lipoprotein Lipase Activity, HDL Cholesterol, and Triglyceride Levels in Coronary Artery Disease Patients: The Ser447-Stop Substitution in the Lipoprotein Lipase Gene Circulation, June 17, 1997; 95(12): 2628 - 2635. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Guerra, J. Wang, S. M. Grundy, and J. C. Cohen A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol PNAS, April 29, 1997; 94(9): 4532 - 4537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Tato, G. L. Vega, and S. M. Grundy Determinants of Plasma HDL-Cholesterol in Hypertriglyceridemic Patients: Role of Cholesterol-Ester Transfer Protein and Lecithin Cholesteryl Acyl Transferase Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 56 - 63. [Abstract] [Full Text]
|
|
|
|
|
|
D. N. Nevin, A. Zambon, C. E. Furlong, R. J. Richter, R. Humbert, J. E. Hokanson, and J. D. Brunzell Paraoxonase Genotypes, Lipoprotein Lipase Activity, and HDL Arterioscler. Thromb. Vasc. Biol., October 1, 1996; 16(10): 1243 - 1249. [Abstract] [Full Text]
|
|
|
|
|
|
K.-i. Hirano, S. Yamashita, Y. Kuga, N. Sakai, S. Nozaki, S. Kihara, T. Arai, K. Yanagi, S. Takami, M. Menju, et al. Atherosclerotic Disease in Marked Hyperalphalipoproteinemia : Combined Reduction of Cholesteryl Ester Transfer Protein and Hepatic Triglyceride Lipase Arterioscler. Thromb. Vasc. Biol., November 1, 1995; 15(11): 1849 - 1856. [Abstract] [Full Text]
|
|
|
|
|
|
P. M. Clifton, M. Abbey, M. Noakes, S. Beltrame, N. Rumbelow, and P. J. Nestel Body Fat Distribution Is a Determinant of the High-Density Lipoprotein Response to Dietary Fat and Cholesterol in Women Arterioscler. Thromb. Vasc. Biol., August 1, 1995; 15(8): 1070 - 1078. [Abstract] [Full Text]
|
|
|
|
|
|
P. Tornvall, G. Olivecrona, F. Karpe, A. Hamsten, and T. Olivecrona Lipoprotein Lipase Mass and Activity in Plasma and Their Increase After Heparin Are Separate Parameters With Different Relations to Plasma Lipoproteins Arterioscler. Thromb. Vasc. Biol., August 1, 1995; 15(8): 1086 - 1093. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |
